Skip to main content

Table 6 Patient characteristics of the previous studies of gefitinib readministration

From: Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis

  

Response to gefitinib

Response to 2nd gefitinib

Author

No. of patients

CR/PR/SD

PD

CR/PR/SD

PD

Yokouchi H et al.

9

9

-

8

1

Yoshimoto A et al.

1

1

-

1

0

Yano S et al.

3

3

-

2

1

Hashimoto N et al.

1

1

-

0

1

Kurata T et al.

1

1

-

1

0

  1. CR, complete response.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us